Cholesterol lowering and cerebrospinal fluid neurotransmitters: Increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteers

Biological Psychiatry

Volumn 40, Issue 4, 1996, Pages 302-304

  Eriksson, Mats ^a   Eklundh, Thomas ^a   Sjöberg, Stefan ^a   Angelin, Bo ^a   Nordin, Conny ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anxiety; Cerebrospinal fluid; Cholecystokinin; Cholesterol; Depression; Simvastatin

Indexed keywords

CHOLECYSTOKININ; CHOLESTEROL; SIMVASTATIN;

ADULT; ANXIETY; ARTICLE; CEREBROSPINAL FLUID; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030586957     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(96)00008-X     Document Type: Article

References (11)

1. Banki CM, Arató M, Papp Z, Kurz M (1994): Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affect Disord 6:341-350.
2. Bradwejn J, Koszycki D, Couetoux de Tertre A, et al (1994): The panicogenic effects of cholescystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51:486-493.
3. Engelberg H (1992): Low serum cholesterol and suicide. Lancet 339:727-728.
4. Frick MH, Elo O, Haapa K, et al (1987): Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. N Engl J Med 317:1237-1245.
5. Grundy SM, Beam AG (1988): The Role of Cholesterol in Atherosclerosis. New Therapeutic Opportunities. Philadelphia: Hanley & Belfus, Inc., p 55.
6. Law MR, Wald NJ, Thompson SG (1994a): By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 308: 367-372.
7. Law MR, Thompson SG, Wald NJ (1994b): Assessing possible hazards of reducing serum cholesterol. Br Med J 308:373-379.
8. Lindberg G, Råstam L, Gullberg B, Eklund GA (1992): Low serum cholesterol concentration and short term mortality from injuries in men and women. Br Med J 305:277-279.
9. Lipid Research Clinics Program (1984): The Lipid Research Clinics Coronory Primary Prevention Trial Results: I. Reduction in incidence of coronary heart disease. JAMA 251:351-364.
10. Milhorat TH, Hammock MK (1983): Cerebrospinal fluid as reflection of internal milieu of brain. In Wood, JH, (ed), Neurobiology of Cerebrospinal Fluid 2. New York and London: Plenum Press, pp 1-24.
11. Scandinavian Simvastatin Survival Study Group (1994): Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383-1389.